Ultrapar Participacoes S.A. (UGP) 19.20 $UGP Ultrapar

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ultrapar Participacoes S.A. (UGP) 19.20 $UGP

Ultrapar Participacoes S. A. (UGP) Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Feb 27, 1:28PM CST

UGP: 19.20 (+0.84)

The Top 10 Midstream Companies
Tyler Crowe, The Motley Fool - Motley Fool - Sun Feb 01, 6:30AM CST
Every year Platts, an energy analyst and consulting group, releases its list of the top 250 energy companies based on five key metrics: total value of assets, total revenue, annual profits, return on invested capital, and three-year compounded annual...
KMI: 42.12 (+0.59), SE: 35.94 (+0.79), TRP: 44.08 (+0.68), OKS: 39.54 (+0.05), ETE: 63.89 (+1.32), ENB: 48.44 (+0.65), UGP: 19.20 (+0.84), CVX: 107.03 (+2.28), PAA: 47.41 (-0.23), EPD: 32.17 (+0.27)

Ultrapar Participacoes Has Returned 13.4% Since SmarTrend Recommendation (UGP)
Comtex SmarTrend(R) - Tue Nov 18, 11:09AM CST
SmarTrend identified a Downtrend for Ultrapar Participacoes (NYSE:UGP) on September 12th, 2014 at $23.37. In approximately 2 months, Ultrapar Participacoes has returned 13.44% as of today's recent price of $20.23.
UGP: 19.20 (+0.84)

Ultrapar Participacoes (UGP) Downgraded From Buy to Hold
at The Street - Mon Nov 10, 8:46AM CST
Ultrapar Participacoes UGP has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C+. TheStreet Ratings Team has this to say about their recommendation:
UGP: 19.20 (+0.84)

Ultrapar Participacoes SA's (UGP) CEO Thilo Mannhardt on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Nov 07, 4:55PM CST

UGP: 19.20 (+0.84)

Ultrapar Participacoes EPS of R$0.59
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 11:14PM CST

UGP: 19.20 (+0.84)

Ultrapar announces its 3Q14 results
PR Newswire - Wed Nov 05, 4:17PM CST
Ultrapar Participacoes S.A. (BM&FBOVESPA: UGPA3 / NYSE: UGP), a multi-business company engaged in specialized distribution and retail (Ultragaz / Ipiranga / Extrafarma), specialty chemicals (Oxiteno) and storage for liquid bulk (Ultracargo), hereby reports its results for the third quarter of 2014.
UGP: 19.20 (+0.84)

Ultrapar Participacoes Down 10.9% Since SmarTrend Downtrend Call (UGP)
Comtex SmarTrend(R) - Tue Nov 04, 9:31AM CST
SmarTrend identified a Downtrend for Ultrapar Participacoes (NYSE:UGP) on September 12th, 2014 at $23.37. In approximately 2 months, Ultrapar Participacoes has returned 10.91% as of today's recent price of $20.82.
UGP: 19.20 (+0.84)

Ultrapar Participacoes Shares Down 16.0% Since SmarTrend's Sell Call (UGP)
Comtex SmarTrend(R) - Fri Oct 24, 9:57AM CDT
SmarTrend identified a Downtrend for Ultrapar Participacoes (NYSE:UGP) on September 12th, 2014 at $23.37. In approximately 1 month, Ultrapar Participacoes has returned 15.96% as of today's recent price of $19.64.
UGP: 19.20 (+0.84)

Ultrapar (UGP): Moving Average Crossover Alert - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 21, 9:08AM CDT
Ultrapar (UGP): Moving Average Crossover Alert
UGP: 19.20 (+0.84)

Downtrend Call Working As Ultrapar Participacoes Stock Falls 13.3% (UGP)
Comtex SmarTrend(R) - Fri Oct 17, 10:02AM CDT
SmarTrend identified a Downtrend for Ultrapar Participacoes (NYSE:UGP) on September 12th, 2014 at $23.37. In approximately 1 month, Ultrapar Participacoes has returned 13.26% as of today's recent price of $20.27.
UGP: 19.20 (+0.84)

Ultrapar Holdings (UGP) Catches Eye: Stock Jumps 8.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 07, 8:21AM CDT
Ultrapar Holdings Inc. (UGP) was a big mover last session, as the company saw its shares rise by over 8% on the day.
TEP: 49.63 (+0.59), NKA: 1.88 (-0.02), CQH: 24.00 (+0.29), UGP: 19.20 (+0.84)

Shares of UGP Down 14.9% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu Oct 02, 9:34AM CDT
SmarTrend identified a Downtrend for Ultrapar Participacoes (NYSE:UGP) on September 12th, 2014 at $23.37. In approximately 3 weeks, Ultrapar Participacoes has returned 14.89% as of today's recent price of $19.89.
UGP: 19.20 (+0.84)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vipshop Prepares for Q3 Financial Results Release

Updated Category News Views 60

Countdown to Vipshop's Third Quarter Results November 24th might just be another day on the calendar for some, but for those of us keeping tabs on the markets, it's a make-or-break moment for Vipshop Holdings Limited. The off-price retail titan from China, trailing under the ticker NYSE:VIPS, is gearing up to swing the doors wide open on its third-quarter financial...

Continue Reading
Orangetheory Adds NASM Training for Coaching Edge

Updated Category News Views 19

A Shift in Coaching Standards Ever seen a fitness brand tilt towards a change so fast it leaves you slack-jawed? Well, here we go with Orangetheory Fitness pushing its chips all in with NASM-certified coaches geared for the GLP-1 era. A bold move? Sure, but they aim to become trendsetters instead of just another player in the fitness game. The Impact of NASM Certification...

Continue Reading
HearUSA Expands Access with AI-Powered Hearing Aids

Updated Category News Views 24

AI Revolution in Hearing Care Look, the hearing aid industry isn't known for headlines that grab you by the throat, but HearUSA just tossed a proverbial grenade into the scene with Widex Allure AI RIC. This is more than a slight tweak in hearing tech—it's a game-changer. We're talking about on-demand AI noise management blended with Widex's renowned natural sound. It's...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 139

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
YYForce's Strategic Play: Robotics and AI Expansion

Updated Category News Views 11

Innovation Meets Pragmatism at YYForce There's a new bout of excitement brewing over at YYForce Inc. (NASDAQ: YFOR), if the latest announcements are anything to go by. The Singapore-based AI-enabled workforce dynamo is laying out priorities like a general plotting a campaign—pragmatic, strategic, and with a keen eye on the bottom line. Aiming for a Technological Edge In...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 150

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 254

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 94

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Asia-Pacific Miracle: New Economic Chapter Unfolds

Updated Category News Views 31

A Fresh Breeze in Asia-Pacific's Sails You ever look around and realize everything's about to change—again? That's Asia-Pacific right now. We're staring down the barrel of a new chapter in what folks are calling the "Asia-Pacific miracle." The text from China Daily paints a picture of a region gearing up to crank the cooperation dial even higher. And where's this...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 343

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading

Top 5 Most Recently Viewed Articles

BitGo Faces Securities Fraud Suit Amid Investor Losses

Updated Category News Views 69

BitGo's Legal Woes: A Deep Dive into the Allegations A lawsuit can shake up a company's foundations, and BitGo Holdings, Inc. (NYSE: BTGO) is feeling the heat right now. The focus of this busy investor morning isn’t some penny stock drama; we're talking about players in the digital asset game accused of pulling the wool over investors' eyes. Slap on those reading...

Continue Reading
Investors Alert: Deadline Approaches in Match Group Lawsuit

Updated Category News Views 141

Important Deadline Approaching for Match Group Investors Recently, there has been a notable reminder for investors concerning a class action lawsuit involving Match Group, Inc. (NASDAQ: MTCH). The law firm Glancy Prongay & Murray LLP has highlighted that all individuals who purchased shares in Match Group during the specified period should be aware of the upcoming...

Continue Reading
Leadership Transition at Coloplast A/S: New Era Begins

Updated Category News Views 937

Coloplast A/S Announces Leadership Change In a significant shift for Coloplast A/S, CEO Kristian Villumsen has officially stepped down. Today marks the start of a new chapter as the Board of Directors mobilizes Lars Rasmussen to serve as interim CEO while the search for a permanent replacement is conducted. Strategic Shift for the Future This change comes at an opportune...

Continue Reading
Johnson & Johnson's Strong Q3 Results Amid Market Declines

Updated Category News Views 109

Market Overview On a day marked by declining values, U.S. stocks experienced a noticeable downturn. The Nasdaq Composite index saw a drop of around 150 points, indicating a challenging market environment. As trading progressed, the Dow Jones Industrial Average slipped slightly, and the S&P 500 also followed suit, showing varied performance across sectors. Sector...

Continue Reading
Moroccanoil Expands Product Line at Ulta Beauty Nationwide

Updated Category News Views 204

Moroccanoil Expands Product Line at Ulta Beauty Nationwide Moroccanoil is thrilled to announce an exciting partnership with Ulta Beauty, the premier beauty retailer in the nation. This significant expansion reaffirms Moroccanoil's commitment to delivering high-quality beauty products to a wider audience while honoring its legacy rooted in the salon community. Launching at...

Continue Reading